Fairfield Financial Advisors »

Structure Therapeutics shares owned by Fairfield Financial Advisors

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Fairfield Financial Advisors from 13F filings

Historical chart of Fairfield Financial Advisors investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Fairfield Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Fairfield Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6k 59 43.90
2024-06-30 $2.3k 59 39.27
2023-12-31 $2.4k 59 40.76

More positions owned by Fairfield Financial Advisors

Invsc Qqq Trust Srs 1 Etf Uit Exchange Traded (QQQ)
Technology Select Sectorspdr Etf Uit Exchange Traded (XLK)
Jensen Quality Growth I Equity Funds (JENIX)
Parnassus Core Equity Investor Ntf Equity Funds (PRBLX)
T. Rowe Price Capital Appreciation I Ntf Equity Funds (TRAIX)
Vanguard Dividend Growth Fund Inv Equity Funds (VDIGX)
Eli Lilly And Common Stock (LLY)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Alphabet Inc Class A Common Stock (GOOGL)
Berkshire Hathaway Class B Common Stock (BRK.B)
Microsoft Corp Common Stock (MSFT)
Automatic Data Processin Common Stock (ADP)
Novo-nordisk A S Fsponsored Adr 1 Adr Reps 1 Ord American Depository (NVO)
Schwab Value Advantage Money Investor Shares Schwab Non-sweep Mmf (SWVXX)

View all positions for Fairfield Financial Advisors

Top funds holding Structure Therapeutics

Capital Research Global Investors
Henderson Group
Driehaus Capital Management
Federated Investors
BVF
T. Rowe Price Associates
RA Capital Management
Citadel Advisors
Logos Global Management
Capital Research and Management Company - Division 3
Point72 Asset Management
Octagon Capital Advisors
Vestal Point Capital
Rock Springs Capital Management
Deep Track Capital

View all funds holding Structure Therapeutics